Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Menu
Streetwise Articles
Biotechnology / Pharmaceuticals
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Regenerative Medicine
Resources
Archives
Helpful Resources
Expert Profiles
Analysts
Newsletter Writers
Sector Experts
NASDAQ News
Directories
Alliance for Regenerative Medicine
Neurotechnology Industry Organization
Featured news in
The Life Sciences Report
Viveve Medical Inc.
(VIVE:NASDAQ)
Viveve Product Review Financial Analysis and Guidance (4/20/2017)
view
RXi Pharmaceuticals Corp.
(RXII:NASDAQ)
RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermatology 76th Annual Meeting (4/20/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
Brainstorm Cell Therapeutics to Present at ARM's 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston (4/20/2017)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT Corporation (DRRX) Gives Up 3.73% at Midday on April 17, Pressuring Health Care Stocks (4/18/2017)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Health Care Firm Caladrius Biosciences Inc. (CLBS) Advances 7.14% at Midday on April 17 (4/18/2017)
view
RXi Pharmaceuticals Corp.
(RXII:NASDAQ)
RXi Pharmaceuticals Corporation (RXII) Gives Up 5.61% at Midday on April 17, Pressuring Health Care Stocks (4/18/2017)
view
RXi Pharmaceuticals Corp.
(RXII:NASDAQ)
RXi Pharmaceuticals Corporation (RXII) Pressures Healthcare Sector with a Slide of 8.25% on April 17 (4/18/2017)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx To Present At 5th Annual Cell & Gene Therapy Investor Day (4/18/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Announces Publication of NurOwn® Autism Research Study (4/19/2017)
view
Viveve Medical Inc.
(VIVE:NASDAQ)
Viveve Medical Inc. reaches new 52-Week High (4/17/2017)
view
3D Signatures Inc.
(DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Announces Relocation to MaRS Discovery District in Toronto (4/18/2017)
view
RXi Pharmaceuticals Corp.
(RXII:NASDAQ)
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes (4/18/2017)
view